Biomaterial Database

[Results of the clinical trial with viloxazine (Vivalan ICI). A part of the multicentre study (author's transl)]. 1979

J Kabes, and T Dostal

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009025	Morpholines		Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D003863	Depression	Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.	Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D014745	Viloxazine	A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.	Emovit,ICI-58,834,Viloxazine Hydrochloride,Viloxazine Hydrochloride, (R)-Isomer,Viloxazine Hydrochloride, (S)-Isomer,Viloxazine Oxalate (1:1),Viloxazine, (+-)-Isomer,Viloxazine, (R)-Isomer,Viloxazine, (S)-Isomer,Vivalan,ICI58,834